APN 2023 - November 29-30
Dear Colleagues,
The 2013 APN Symposium will be held online on November 29-30.
While this year's symposium was originally planned for an offline event after
the end of the COVID-19 pandemic, due to various circumstances during the
preparation process, it will be held as an offline event. We ask for your
understanding, and we would like to inform you that next year's symposium will
be hosted in Japan as an offline event.
Since its inception, APN has invited speakers from over ten APN countries for
the annual symposium, with a mission to promote the development of
Pharmacometrics in the Asian region and enhance networking opportunities.
Through these efforts, the APN Symposium has become a well-established
pan-Asian conference in the field of quantitative pharmacology, and we are very
proud and pleased about this.
This year, we have also invited various speakers from different Asian
countries. For information regarding the program and registration (registration
period: November 10 ~ 23, JST), please refer to the following link:
https://apn-tokyo.jp/
For further details, please contact Dr. Atsunori Kaibara of the Conference
Organizing Committee at
[email protected]<mailto:[email protected]>
Thank you.
APN Chair
Kyungsoo Park
---------------------------------------
Kyungsoo Park, PhD, MD
Professor of Pharmacology
Yonsei University College of Medicine
50-1 Yonsei-Ro, Seoul 03722, Korea
Tel +82-2-2228-1735 / Fax +82-2-313-1894
상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는
영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는
사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above
message is intended solely for the named addressee and may contain trade
secret, industrial technology or privileged and confidential information
otherwise protected under applicable law including the Unfair Competition
Prevention and Trade Secret protection act. Any unauthorized dissemination,
distribution, copying or use of the information contained in this communication
is strictly prohibited. If you have received this communication in error,
please notify the sender by email and delete this communication immediately.